Minnesota has become the second state to sue L’Oréal over a potential cancer risk tied to its hair relaxer products.

Abbott plans to spin off its baby formula business in 2027 amid millions of dollars in injury settlements and jury verdicts.

Legal Client Twenty-two vials of a compounded GLP-1 drug have been recalled. Apothecary Pharma, which had previously received ...

Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review. Drugwatch.com's trusted legal partners support the ...

The Cartiva toe implant is used to treat big toe arthritis. About the size of a bullet, it serves as an alternative to joint fusion surgery. In 2024, Stryker issued a recall of all Cartiva implants ...

Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by The Wilson Firm LLP, we've pursued justice for more ...

Talc, commonly found in cosmetics and makeup, has raised safety concerns due to potential contamination with asbestos, a toxic mineral. Lawsuits have been filed by individuals who claim their ...

Thousands of lawsuits allege hair relaxers cause uterine, ovarian and endometrial cancer, and that brands like L'Oréal and Revlon failed to warn consumers of the risks. Lawsuits also allege ...

Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by The Wilson Firm LLP, we've pursued justice for more ...